Preparing for PGT When a Chromosome Rearrangement Is Already Known

A chromosome rearrangement on a report changes the PGT conversation in a specific way. You are not asking whether genetic testing exists in general. You are asking whether a laboratory can build a test around your rearrangement, how it will report the results, and what happens when the answer is unclear.

That makes the first useful step a records step, not a booking step. Before a clinic can say anything meaningful about PGT for structural rearrangements (PGT-SR), it needs the actual laboratory report, not a summary such as “a balanced translocation was found.”

Start with the report, not the diagnosis label

PGT-SR is designed for people who carry a known chromosomal structural rearrangement. It addresses a different question from PGT-M, which concerns a known single-gene condition. The two tests are not interchangeable, and a treating team together with a genetic counsellor should review the relevant history, the test design and whether testing is suitable at all (HFEA: PGT-M and PGT-SR).

In practice, that review begins with the karyotype or other cytogenetic report. Ask the genetics service or clinic that produced it for the full document, including the written interpretation, not only the conclusion line. If the finding came from a different technique, such as FISH or a microarray, request that report too, because the information it contains is not identical.

Useful details to have in front of you:

• The exact rearrangement named in the report, including the chromosomes involved and the described breakpoints
• Whether it is described as balanced or unbalanced, and whether the report uses a different term
• Whether the report states it was inherited or arose newly (de novo), and on what basis
• Whether a partner has been tested, and whether that result is on file
• Any prior pregnancy, miscarriage or products-of-conception testing records that relate to the rearrangement

You do not need to interpret these documents yourself. The point is to arrive at the consultation with the source material rather than a remembered summary, so the clinician can work from the same facts you are working from.

Questions that belong to the clinical team

These are legitimate questions for a licensed clinician or genetic counsellor. Ask them directly, and ask for the answers in writing where you can, because PGT planning often spans several conversations and sometimes more than one clinic.

About the rearrangement itself

• Can you explain my rearrangement in plain language, including what it may mean for pregnancies?
• Is it inherited, and should my partner or other family members be offered testing?
• Does anything in my history change how you would approach PGT?

About the test design

• Has your laboratory validated a PGT-SR protocol for this specific rearrangement, rather than for rearrangements of this general type?
• What information or samples do you need from me before the test can be designed?
• How long does that preparation take, and does it need to happen before a stimulation cycle starts?

About results and uncertainty

• How will balanced and unbalanced results be reported, and in what wording?
• What happens if a result is inconclusive or cannot be interpreted?
• What does the report tell us about the sampled cells, and what can it not tell us about the whole embryo?
• Would you recommend confirmatory testing during pregnancy, and how would that be arranged?

That last group matters because a PGT result is a laboratory finding from a small sample, not a guarantee. PGT-A, the chromosome-number test, is described by the UK regulator as having limitations and as capable of producing incorrect findings, and a result does not guarantee a successful pregnancy or a healthy child (HFEA: PGT-A). The same caution applies to how you read any PGT report: treat it as information to discuss, not a verdict.

Related reporting questions come up with mosaic findings, where an intermediate result is inferred from the biopsy sample. Technical factors can contribute to such findings, and a sampled result does not establish the cell composition of the whole embryo; the uncertainty should be discussed with the treating clinician and genetic counsellor (ASRM: mosaic PGT-A results). If your clinic mentions mosaicism alongside your rearrangement, ask how the two are being reported separately.

Timing: what has to happen before what

With a known rearrangement, the sequence usually matters more than the calendar. Test design and genetic counselling generally need to be settled before embryo testing can mean anything, and that preparation may involve records from a genetics service in your home country. Ask the clinic to lay out the order of steps and mark which ones depend on documents you still need to obtain.

A practical way to hold this together is a simple two-column list: what the clinic must confirm, and what you must supply. Typical items on your side include the full cytogenetic report, partner testing status, prior pregnancy records and any previous PGT or prenatal reports. Typical items on the clinic side include whether their platform covers your rearrangement, how they report inconclusive results, and who provides genetic counselling and in what language.

If you are comparing more than one clinic, compare those answers rather than headline claims. A general overview of PGT-SR for patients with structural chromosomal rearrangements can help you frame the same questions consistently across providers, and a comparison of PGT-A, PGT-M and PGT-SR is useful if you are still working out which test is being discussed. For the wider treatment sequence, see the step-by-step overview of PGT IVF in Thailand.

Preparing for a remote consultation from abroad

Many international patients have their first substantive conversation before travelling. That conversation is more useful when the clinic already has your records. Ask what format they prefer for scanned reports, whether translated summaries are needed, and who will read the file before the appointment.

It also helps to agree, in advance, who answers what. A genetic counsellor may handle questions about the rearrangement and family testing; the fertility clinician may handle cycle planning; a coordinator may handle scheduling and document requests. Coordination support can include organising records, requesting appointments and confirming the format of a remote consultation, but clinical interpretation and any treatment decision stay with the treating team.

Before you travel, confirm the appointment location, the language in which counselling will be provided, and whether any part of the test preparation must be completed in your home country. These are logistics questions, and they are worth settling early because they can affect when a cycle is realistically possible.

After the cycle: results, handover and follow-up

Ask in advance how results will be communicated, who will explain them, and what records you will receive to take home. If you plan to continue care with a clinician in your own country, ask what documentation they would find useful and request it before you leave. Confirmatory prenatal testing, if recommended, is arranged through your maternity pathway, so ask how that referral is expected to work.

One reminder that applies throughout: keep your own dated copy of every report and do not change any medication on the basis of something you have read online. Questions about your diagnosis, your options, your risks and your individual chances belong with your licensed clinicians, and it is reasonable to keep asking until the answers make sense to you.

Frequently asked questions

Does a known rearrangement mean PGT is definitely right for me?

Not automatically. PGT-SR is designed for people with a known structural rearrangement, but whether testing is suitable, and how it should be designed, depends on your specific report and history. A treating team and genetic counsellor should review those with you before you commit to a plan.

What if my clinic has not tested this exact rearrangement before?

Ask directly whether their laboratory has validated a protocol for your specific rearrangement, and what they would need from you to design one. If the answer is unclear, that is a reasonable point to seek a second clinical opinion before starting a cycle.